CDK6 and ovarian carcinoma: In particular, cells can become sensitized to cisplatin after ATR depletion [40]; a recent report shows that CDK6 regulates transcription of ATR, and that CDK6 inhibition therefore sensitizes epithelial ovarian cancer cells to death from cisplatin due to an impaired DNA damage response [41].